GSK
706 hedge funds and large institutions have $8.53B invested in GSK in 2015 Q3 according to their latest regulatory filings, with 46 funds opening new positions, 261 increasing their positions, 264 reducing their positions, and 51 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less first-time investments, than exits
New positions opened: | Existing positions closed:
2% less funds holding
Funds holding: 719 → 706 (-13)
12% less capital invested
Capital invested by funds: $9.69B → $8.53B (-$1.15B)
18% less funds holding in top 10
Funds holding in top 10: 11 → 9 (-2)
Holders
706
Holding in Top 10
9
Calls
$182M
Puts
$115M
Top Buyers
| 1 | +$181M | |
| 2 | +$86.2M | |
| 3 | +$77.8M | |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$70.7M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$50M |
Top Sellers
| 1 | -$472M | |
| 2 | -$74.9M | |
| 3 | -$69.8M | |
| 4 |
Invesco
Atlanta,
Georgia
|
-$65.8M |
| 5 |
Barclays
London,
United Kingdom
|
-$35.8M |